Circulating Biomarkers From the Phase 1 Trial of Sirolimus and Autophagy Inhibition for Patients With Lymphangioleiomyomatosis

Authors:

Abstract
No abstract available
Funding Information
  • U.S. Department of War (W81XWH-12-1-0578)
  • National Heart, Lung, and Blood Institute (W81XWH-12-1-0578)
  • National Institutes of Health (W81XWH-12-1-0578)

This publication has 42 references indexed in Scilit: